CANNONE, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 2.262
AS - Asia 2.003
EU - Europa 859
SA - Sud America 314
AF - Africa 97
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.541
Nazione #
US - Stati Uniti d'America 2.211
SG - Singapore 870
CN - Cina 675
IE - Irlanda 278
BR - Brasile 259
HK - Hong Kong 167
SE - Svezia 137
VN - Vietnam 101
ZA - Sudafrica 80
DE - Germania 77
NL - Olanda 77
TR - Turchia 75
IT - Italia 58
FI - Finlandia 41
RU - Federazione Russa 37
CA - Canada 31
AR - Argentina 27
GB - Regno Unito 27
IN - India 25
PL - Polonia 24
FR - Francia 20
BE - Belgio 18
AT - Austria 16
JP - Giappone 15
MX - Messico 15
TW - Taiwan 13
BD - Bangladesh 10
ES - Italia 10
VE - Venezuela 8
EC - Ecuador 7
ID - Indonesia 7
IQ - Iraq 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
UZ - Uzbekistan 5
AL - Albania 4
CO - Colombia 4
OM - Oman 4
PE - Perù 4
PK - Pakistan 4
RO - Romania 4
AZ - Azerbaigian 3
EG - Egitto 3
KR - Corea 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
AU - Australia 2
BW - Botswana 2
CH - Svizzera 2
CR - Costa Rica 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
NP - Nepal 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
MZ - Mozambico 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TM - Turkmenistan 1
Totale 5.541
Città #
Singapore 388
Ashburn 294
Santa Clara 292
Dublin 277
Chandler 264
Beijing 229
Hong Kong 167
Dallas 134
Ann Arbor 128
Dearborn 88
Nanjing 81
Boardman 78
Johannesburg 74
Izmir 69
Princeton 61
Houston 42
Wilmington 42
Shanghai 33
Ho Chi Minh City 32
Moscow 28
Woodbridge 28
Helsinki 27
Kunming 27
São Paulo 27
Los Angeles 26
Seattle 24
Bremen 23
Parma 21
Warsaw 21
Columbus 19
Munich 19
Nanchang 19
Brussels 18
Fremont 18
Shenyang 18
Hefei 17
New York 17
Tianjin 16
Changsha 15
Hanoi 15
Tokyo 15
Hebei 14
Jiaxing 14
Turku 14
Taipei 13
The Dalles 13
Brooklyn 12
Montreal 12
Nuremberg 12
Boston 11
Guangzhou 11
Jinan 11
Vienna 11
Rio de Janeiro 10
Buffalo 9
Chicago 9
San Mateo 9
Frankfurt am Main 8
Norwalk 8
Porto Alegre 8
Redmond 8
Da Nang 7
Haiphong 7
Reggio Emilia 7
Rockville 7
Stockholm 7
Belo Horizonte 6
Fortaleza 6
Mexico City 6
Pune 6
Amsterdam 5
Biên Hòa 5
Borås 5
Brasília 5
Council Bluffs 5
Denver 5
Des Moines 5
Jakarta 5
Milan 5
Ottawa 5
Phoenix 5
San Francisco 5
Sorocaba 5
Tashkent 5
Vancouver 5
Wuhan 5
Campinas 4
Chengdu 4
Curitiba 4
Hangzhou 4
Jacksonville 4
Juiz de Fora 4
London 4
Orem 4
Salvador 4
Shijiazhuang 4
Toronto 4
Washington 4
Xian 4
Angra dos Reis 3
Totale 3.642
Nome #
Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease 167
Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis 159
Electrolyte Disorders Induced by Antineoplastic Drugs 138
NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis 123
Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats 119
Posterior reversible encephalopathy syndrome in an oncological normotensive patient: Evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment 116
Association of NPPA rs5065 Genetic Variant With Increased Cardiovascular Risk in the General USA Population 109
Bisphosphonate-associated femoral fracture: Implications for management 106
Aging and oral health: Effects in hard and soft tissues 106
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study 105
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator 103
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease 100
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA) 99
A cardio-metabolic phenotype in carriers of NPPA (rs5086) and NPPB (rs198389) gene variants in the general population: the dominant role of ANP 96
An update on rickettsiosis 96
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up 93
A Genetic Variant of the ANP Gene Is Associated With a Lower Cardiometabolic Risk Profile in the General USA Population 93
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: A 9-year follow-up study 91
Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population 91
Hypokalemic rhabdomyolysis in a patient with a laparoscopic adjustable gastric banding 89
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease 89
An atrial natriuretic peptide genetic variant (rs5065) in the general US population identifies risk for cerebrovascular accidents 88
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure 87
A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community 86
PRESENCE OF A NATRIURETIC PEPTIDE DEFICIENCY STATE AMONGST PATIENTS DIAGNOSED WITH HYPERTENSION 84
Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP 84
A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA) 83
A genetic variant of the NPPA gene (rs5068) is associated with increased NT-ANP levels and reduced cardiometabolic risk 82
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa 81
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community 81
DIFFERENTIAL REGULATION OF CIRCULATING CARDIAC NATRIURETIC PEPTIDES IN HUMAN ACUTE DECOMPENSATED HEART FAILURE: EVIDENCE FOR A SELECTIVE AND RELATIVE ATRIAL NATRIURETIC PEPTIDE DEFICIENCY 80
Can a cardiac peptide predict mortality in human hypertension? 80
Chronic Renal Insufficiency: Prevalence in the General Population and Improved Detection of Cardiac Disease in Combination with BNP Assays 80
Metabolic disease in the general population: a potential cyclic GMP deficiency states 80
MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease 78
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure 77
The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial 76
Mineral bone diseases and thermal walter therapy hot mud bath 74
Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism 74
CHARACTERIZATION OF ANP GENETIC VARIANT RS5068 IN CHRONIC HEART FAILURE PATIENTS 74
Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: A metabolic link with the cardiac natriuretic pathway 73
IN-DEPTH PHENOTYPE OF SUBJECTS WITH INCREASED HEART FAILURE RISK BASED ON B-TYPE NATRIURETIC PEPTIDE 73
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation 72
MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease 72
Circulating aldosterone predicts future cardiorenal and metabolic disease in the general community 71
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population 69
Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases 68
Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community 68
Plasma Aldosterone and Heart Failure in the General Community 67
THE BNP GENETIC VARIANT RS198389: HYPERTENSION RISK AND CARDIOVASCULAR PHENOTYPE IN STAGE A AND STAGE B HEART FAILURE SUBJECTS FROM THE STOP-HF TRIAL 67
MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure 66
Evidence of autonomic dysregulation in otherwise healthy cancer caregivers: A possible link with health hazard 66
In Vitro and In Vivo Actions of a Novel ANP Genetic Variant: Unique Actions on Human Endothelial Cells 66
Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis) 65
Circulating aldosterone and natriuretic peptides in the general community relationship to cardiorenal and metabolic disease 64
Circulating molecular forms of ANP and BNP in human acute decompensated heart failure: evidence for a relative ANP deficiency state 64
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure 63
Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure 63
The malnutrition in the elderly: A clinical approach 62
Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension 59
The Soluble Guanylate Cyclase Genetic Variant rs13139571 Is Associated with an “Unfavorable” Metabolic Phenotype in an US General Community 59
Circulating corin in the general community: link to gender and metabolic dysfunction 57
Natriuretic peptide pathways in heart failure: further therapeutic possibilities 55
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension 53
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure 53
The role of OPG, RANK, RANKL in the bone metabolism, cardiovascular disease and immune system: Clinical and physiopathological implication 53
Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population 51
Circulating Corin in the General Community: A Link to Gender and Metabolic Phenotype 51
Necrotizing fasciitis of the face: A life-threatening condition 49
Totale 5.636
Categoria #
all - tutte 23.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 13 10 11 26 5 10 8
2021/2022224 7 7 4 4 7 2 17 28 11 13 9 115
2022/2023962 109 87 20 72 94 87 7 89 341 2 31 23
2023/2024353 29 34 14 13 41 71 16 34 17 22 31 31
2024/20251.553 5 74 92 55 206 263 33 66 207 160 110 282
2025/20261.609 284 288 399 205 416 17 0 0 0 0 0 0
Totale 5.636